261 related articles for article (PubMed ID: 19720803)
1. Fibroblast growth factor-21 is induced in human skeletal muscles by hyperinsulinemia.
Hojman P; Pedersen M; Nielsen AR; Krogh-Madsen R; Yfanti C; Akerstrom T; Nielsen S; Pedersen BK
Diabetes; 2009 Dec; 58(12):2797-801. PubMed ID: 19720803
[TBL] [Abstract][Full Text] [Related]
2. Free fatty acids link metabolism and regulation of the insulin-sensitizing fibroblast growth factor-21.
Mai K; Andres J; Biedasek K; Weicht J; Bobbert T; Sabath M; Meinus S; Reinecke F; Möhlig M; Weickert MO; Clemenz M; Pfeiffer AF; Kintscher U; Spuler S; Spranger J
Diabetes; 2009 Jul; 58(7):1532-8. PubMed ID: 19401423
[TBL] [Abstract][Full Text] [Related]
3. Expression of fibroblast growth factor-21 in muscle is associated with lipodystrophy, insulin resistance and lipid disturbances in patients with HIV.
Lindegaard B; Hvid T; Grøndahl T; Frosig C; Gerstoft J; Hojman P; Pedersen BK
PLoS One; 2013; 8(3):e55632. PubMed ID: 23533568
[TBL] [Abstract][Full Text] [Related]
4. Circulating fibroblast growth factor-21 is elevated in impaired glucose tolerance and type 2 diabetes and correlates with muscle and hepatic insulin resistance.
Chavez AO; Molina-Carrion M; Abdul-Ghani MA; Folli F; Defronzo RA; Tripathy D
Diabetes Care; 2009 Aug; 32(8):1542-6. PubMed ID: 19487637
[TBL] [Abstract][Full Text] [Related]
5. Long-term high-fat diet links the regulation of the insulin-sensitizing fibroblast growth factor-21 and visfatin.
Sun B; Yang G; Yang M; Liu H; Boden G; Li L
Cytokine; 2012 Jul; 59(1):131-7. PubMed ID: 22542568
[TBL] [Abstract][Full Text] [Related]
6. Serum concentrations of fibroblast growth factor 19 in patients with obesity and type 2 diabetes mellitus: the influence of acute hyperinsulinemia, very-low calorie diet and PPAR-α agonist treatment.
Mráz M; Lacinová Z; Kaválková P; Haluzíková D; Trachta P; Drápalová J; Hanušová V; Haluzík M
Physiol Res; 2011; 60(4):627-36. PubMed ID: 21574752
[TBL] [Abstract][Full Text] [Related]
7. Chronic hyperinsulinemia contributes to insulin resistance under dietary restriction in association with altered lipid metabolism in Zucker diabetic fatty rats.
Morita I; Tanimoto K; Akiyama N; Naya N; Fujieda K; Iwasaki T; Yukioka H
Am J Physiol Endocrinol Metab; 2017 Apr; 312(4):E264-E272. PubMed ID: 28143857
[TBL] [Abstract][Full Text] [Related]
8. Effects of short-term continuous subcutaneous insulin infusion on fasting plasma fibroblast growth factor-21 levels in patients with newly diagnosed type 2 diabetes mellitus.
Yang M; Dong J; Liu H; Li L; Yang G
PLoS One; 2011; 6(10):e26359. PubMed ID: 22046277
[TBL] [Abstract][Full Text] [Related]
9. Chronic physiologic hyperinsulinemia impairs suppression of plasma free fatty acids and increases de novo lipogenesis but does not cause dyslipidemia in conscious normal rats.
Koopmans SJ; Kushwaha RS; DeFronzo RA
Metabolism; 1999 Mar; 48(3):330-7. PubMed ID: 10094109
[TBL] [Abstract][Full Text] [Related]
10. No major sex differences in muscle protein synthesis rates in the postabsorptive state and during hyperinsulinemia-hyperaminoacidemia in middle-aged adults.
Smith GI; Atherton P; Reeds DN; Mohammed BS; Jaffery H; Rankin D; Rennie MJ; Mittendorfer B
J Appl Physiol (1985); 2009 Oct; 107(4):1308-15. PubMed ID: 19644030
[TBL] [Abstract][Full Text] [Related]
11. Characterization of an early decline in baseline plasma glucose concentration after acute insulin elevation during euglycemic hyperinsulinemic clamp in patients with type 2 diabetes mellitus.
Wasada T; Kuroki H; Arii H; Sato A; Katsumori K; Saito S; Iwamoto Y
Endocr J; 2000 Jun; 47(3):309-16. PubMed ID: 11036875
[TBL] [Abstract][Full Text] [Related]
12. Acute hyperinsulinemia is followed by increased serum concentrations of fibroblast growth factor 23 in type 2 diabetes patients.
Winther K; Nybo M; Vind B; Pedersen SM; Højlund K; Rasmussen LM
Scand J Clin Lab Invest; 2012 Apr; 72(2):108-13. PubMed ID: 22133206
[TBL] [Abstract][Full Text] [Related]
13. Skeletal muscle peroxisome proliferator- activated receptor-gamma expression in obesity and non- insulin-dependent diabetes mellitus.
Kruszynska YT; Mukherjee R; Jow L; Dana S; Paterniti JR; Olefsky JM
J Clin Invest; 1998 Feb; 101(3):543-8. PubMed ID: 9449686
[TBL] [Abstract][Full Text] [Related]
14. Physiological modulation of circulating FGF21: relevance of free fatty acids and insulin.
Mai K; Bobbert T; Groth C; Assmann A; Meinus S; Kraatz J; Andres J; Arafat AM; Pfeiffer AF; Möhlig M; Spranger J
Am J Physiol Endocrinol Metab; 2010 Jul; 299(1):E126-30. PubMed ID: 20424140
[TBL] [Abstract][Full Text] [Related]
15. Association between insulin resistance and impairment of FGF21 signal transduction in skeletal muscles.
Jeon JY; Choi SE; Ha ES; Kim TH; Jung JG; Han SJ; Kim HJ; Kim DJ; Kang Y; Lee KW
Endocrine; 2016 Jul; 53(1):97-106. PubMed ID: 26758997
[TBL] [Abstract][Full Text] [Related]
16. Hyperinsulinemia is associated with the loss of appendicular skeletal muscle mass at 4.6 year follow-up in older men and women.
López Teros MT; Ramírez C FA; Alemán-Mateo H
Clin Nutr; 2015 Oct; 34(5):931-6. PubMed ID: 25453394
[TBL] [Abstract][Full Text] [Related]
17. Circulating FGF-21 levels in normal subjects and in newly diagnose patients with Type 2 diabetes mellitus.
Chen WW; Li L; Yang GY; Li K; Qi XY; Zhu W; Tang Y; Liu H; Boden G
Exp Clin Endocrinol Diabetes; 2008 Jan; 116(1):65-8. PubMed ID: 17926232
[TBL] [Abstract][Full Text] [Related]
18. Relationship of hepatic and peripheral insulin resistance with plasminogen activator inhibitor-1 in Pima Indians.
Nagi DK; Tracy R; Pratley R
Metabolism; 1996 Oct; 45(10):1243-7. PubMed ID: 8843179
[TBL] [Abstract][Full Text] [Related]
19. Acute hyperinsulinemia raises plasma interleukin-6 in both nondiabetic and type 2 diabetes mellitus subjects, and this effect is inversely associated with body mass index.
Ruge T; Lockton JA; Renstrom F; Lystig T; Sukonina V; Svensson MK; Eriksson JW
Metabolism; 2009 Jun; 58(6):860-6. PubMed ID: 19375766
[TBL] [Abstract][Full Text] [Related]
20. Glucose-dependent inflammatory responses in obese compared to lean individuals.
Lundqvist MH; Pereira MJ; Eriksson JW
Endocrine; 2023 Sep; 81(3):464-476. PubMed ID: 37400734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
